Condensed Statements of Operations (Unaudited) - USD ($)		3 Months Ended		9 Months Ended
		Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Net sales		$ 4,743,452	$ 3,134,984	$ 12,068,208	$ 9,204,615
Cost of goods sold		3,161,362	2,261,205	8,060,482	6,792,709
GROSS PROFIT		1,582,090	873,779	4,007,726	2,411,906
SELLING, GENERAL AND ADMINISTRATIVE EXPENSES	[1]	2,274,054	979,773	5,402,147	3,963,100
RESEARCH AND DEVELOPMENT EXPENSES	[1]	134,608	136,520	398,425	521,334
LOSS FROM OPERATIONS		(826,572)	(242,514)	(1,792,846)	(2,072,528)
INTEREST EXPENSE		(103)	(24,592)	(102,443)	(70,699)
OTHER INCOME		20	39	5,195	8,722
LOSS BEFORE INCOME TAXES		(826,655)	(267,067)	(1,890,094)	(2,134,505)
INCOME TAX EXPENSE (BENEFIT)		25,081	6,929	5,557	(232,000)
NET LOSS		$ (851,736)	$ (273,996)	$ (1,895,651)	$ (1,902,505)
LOSS PER COMMON SHARE
Basic (in dollars per share)		$ (0.43)	$ (0.14)	$ (0.96)	$ (0.96)
Diluted (in dollars per share)		$ (0.43)	$ (0.14)	$ (0.96)	$ (0.96)
WEIGHTED AVERAGE COMMON SHARES OUTSTANDING
Basic (in shares)		1,981,138	1,976,354	1,978,638	1,976,354
Diluted (in shares)		1,981,138	1,976,354	1,978,638	1,976,354

[1] The Company does not allocate all selling, general and administrative expenses or any research and development expenses to its operating segments for internal reporting.